ArticleBasic and clinical neuroscience2025
Detecting Mild Cognitive Impairment to Alzheimer's Disease Progression by fMRI Using Convolutional Neural Network and Long-short Term Memory.
Article in Basic and clinical neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Mild cognitive impairment (MCI) is the stage that occurs before Alzheimer's disease (AD), and there is a high risk of progression to AD. However, this progression is not guaranteed, and there is a chance of remaining at this stage. This study aimed to diagnose possible AD progression among patients with MCI using a combination of resting-state functional magnetic resonance imaging (fMRI), clinical assessment, and demographic information for starting treatments in case of progression or reducing medical expenses in case of future stability. Methods: Deep learning (DL) methods, including three-dimensional convolutional neural networks (CNN) and long short-term memory (LSTM) networks, were used in this study. The models were developed using 266 samples from 81 MCI subjects, with an average of five years between baseline and the last timepoint. Results: The results showed that the best validation scores were achieved by the CNN-LSTM model after integrating clinical attributes, with an accuracy of 92.47%. Conclusion: The proposed algorithm demonstrated high performance in predicting MCI-to-AD progression, indicating the potential of DL approaches for processing fMRI data and the efficiency of data type integration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.